Skip to main content
  1. Market Insights
  2. Health
  3. OTC Pharmaceuticals

Digestives & Intestinal Remedies - Montenegro

Montenegro
  • in Montenegro, a country in southeastern Europe, experiences revenue in the Digestives & Intestinal Remedies market market amounting to US$2.89m in 2025.
  • It is projected that the market will grow annually by 1.93% (CAGR 2025-2029).
  • When compared globally, it is noteworthy that China generates the highest revenue in this market, reaching US$4.45bn in 2025.
  • In terms of per person revenues, in Montenegro generates US$4.62 in 2025.
  • Montenegro's growing interest in natural and herbal remedies has led to an increase in demand for digestive and intestinal remedies in the OTC pharmaceuticals market.

Definition:
The Digestives and Intestinal Remedies market comprises over-the-counter natural and synthetic digestive agents and remedies against gastrointestinal complaints. Digestives include preparations in the form of pills, powder, capsules, liquids, solutions, suspensions, drops and suppositories. Not included are prescription medicines, preparations that are against the state law or are not explicit digestive drugs (e.g. painkillers). Among the top-selling digestives are Perenterol, Iberogast, Dulcolax and Buscopan Plus. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Additional information:
The Digestives and Intestinal Remedies market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

In-Scope
  • Natural and synthetic agents
  • Digestive medicines
  • Remedies against gastrointestinal complaints
Out-Of-Scope
  • Prescription medicines
  • Homeopathic remedies
  • Tea
Digestives & Intestinal Remedies: market data & analysis - Cover

Market Insights report

Digestives & Intestinal Remedies: market data & analysis
Study Details

    Revenue

    Notes: Data shown is using current exchange rates and reflects market impacts of the Russia-Ukraine war.

    Most recent update:

    Source: Statista Market Insights

    Most recent update:

    Source: Statista Market Insights

    Notes: The chart “Comparable Estimates” shows the forecasted development of the selected market from different sources. Please see the additional information for methodology and publication date.

    Most recent update:

    Analyst Opinion

    The Digestives & Intestinal Remedies market in Montenegro is experiencing steady growth due to changing customer preferences and increasing demand for digestive health products.

    Customer preferences:
    Customers in Montenegro are becoming more health-conscious and are actively seeking products that promote digestive health. This shift in preferences is driven by a growing awareness of the importance of maintaining a healthy gut and the impact it has on overall well-being. As a result, there is a rising demand for digestive remedies and supplements that aid in digestion, relieve constipation, and promote gut health.

    Trends in the market:
    One of the key trends in the Digestives & Intestinal Remedies market in Montenegro is the increasing popularity of natural and herbal remedies. Customers are now gravitating towards products that are made from natural ingredients and have minimal side effects. This trend is driven by a desire for more holistic and sustainable healthcare solutions. As a result, companies in the market are focusing on developing and promoting natural digestive remedies to cater to this demand.Another trend in the market is the rising popularity of probiotics and prebiotics. Probiotics are live bacteria that are beneficial for gut health, while prebiotics are non-digestible fibers that promote the growth of beneficial bacteria in the gut. Customers in Montenegro are increasingly recognizing the benefits of these products in maintaining a healthy digestive system and are incorporating them into their daily routines. This has led to an increase in the demand for probiotic and prebiotic supplements and foods.

    Local special circumstances:
    Montenegro is a small country with a growing tourism industry. Many tourists visit Montenegro for its natural beauty and cultural heritage. As a result, the country experiences a seasonal influx of tourists, especially during the summer months. This presents an opportunity for the Digestives & Intestinal Remedies market, as tourists may require digestive remedies due to changes in diet and travel-related digestive issues. Companies in the market can capitalize on this by targeting tourists with specific products and marketing campaigns.

    Underlying macroeconomic factors:
    Montenegro has been experiencing steady economic growth in recent years, which has led to an increase in disposable income. As a result, consumers have more purchasing power and are willing to spend on health and wellness products, including digestive remedies. The growing middle class in Montenegro is also contributing to the growth of the Digestives & Intestinal Remedies market, as they have higher health awareness and are willing to invest in products that improve their overall well-being.In conclusion, the Digestives & Intestinal Remedies market in Montenegro is witnessing growth due to changing customer preferences towards natural and herbal remedies, the rising popularity of probiotics and prebiotics, and the country's growing tourism industry. These trends, coupled with the underlying macroeconomic factors of economic growth and increasing disposable income, are driving the development of the market.

    Key Players

    Most recent update:

    Source: Statista Market Insights

    Sales Channels

    Most recent update:

    Source: Statista Market Insights

    Global Comparison

    Most recent update:

    Source: Statista Market Insights

    Methodology

    Data coverage:

    Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

    Modeling approach / Market size:

    Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

    Forecasts:

    In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

    Additional notes:

    Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

    Health

    Access more Market Insights on Health topics with our featured report

    Digestives & Intestinal Remedies: market data & analysis - BackgroundDigestives & Intestinal Remedies: market data & analysis - Cover

    Key Market Indicators

    Notes: Based on data from IMF, World Bank, UN and Eurostat

    Most recent update:

    Source: Statista Market Insights

    Explore more high-quality data on related topic

    Global pharmaceutical industry - statistics & facts

    The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.
    More data on the topic

    Contact

    Get in touch with us. We are happy to help.
    Meredith Alda
    Sales Manager

    Mon - Fri, 9am - 6pm (EST)

    Lodovica Biagi
    Director of Operations

    Mon - Fri, 9:30am - 5pm (GMT)

    Ayana Mizuno
    Junior Business Development Manager

    Mon - Fri, 10:00am - 6:00pm (JST)

    Carolina Dulin
    Group Director - LATAM

    Mon - Fri, 9am - 6pm (EST)

    Yolanda Mega
    Operations Manager

    Mon - Fri, 9am - 5pm (SGT)